Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crinetics Pharmaceuticals (CRNX) Change in Cash: 2016-2024

Historic Change in Cash for Crinetics Pharmaceuticals (CRNX) over the last 9 years, with Dec 2024 value amounting to $209.6 million.

  • Crinetics Pharmaceuticals' Change in Cash rose 278.47% to $57.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$206.4 million, marking a year-over-year decrease of 218.28%. This contributed to the annual value of $209.6 million for FY2024, which is 843.34% up from last year.
  • Per Crinetics Pharmaceuticals' latest filing, its Change in Cash stood at $209.6 million for FY2024, which was up 843.34% from $22.2 million recorded in FY2023.
  • Over the past 5 years, Crinetics Pharmaceuticals' Change in Cash peaked at $209.6 million during FY2024, and registered a low of -$167.2 million during FY2022.
  • Moreover, its 3-year median value for Change in Cash was $22.2 million (2023), whereas its average is $21.6 million.
  • Its Change in Cash has fluctuated over the past 5 years, first skyrocketed by 1,235.38% in 2020, then crashed by 255.40% in 2022.
  • Over the past 5 years, Crinetics Pharmaceuticals' Change in Cash (Yearly) stood at $52.8 million in 2020, then spiked by 103.95% to $107.6 million in 2021, then plummeted by 255.40% to -$167.2 million in 2022, then skyrocketed by 113.29% to $22.2 million in 2023, then soared by 843.34% to $209.6 million in 2024.